Literature DB >> 11903930

Immunoreactivity for Bcl-2 and C-Jun/AP1 in hippocampal corpora amylacea after ischaemia in humans.

G Botez1, A Rami.   

Abstract

Corpora amylacea (CAm) are regarded as a hallmark of brain ageing, but little is known about their role in normal and pathological circumstances. CAm contain, in addition to glucose polymers, ageing-, stress- and proinflammatory proteins. In view of their almost universal occurrence and their cumulation with time, formation of CAm may represent a basic mechanism for the management of metabolic degradation products. In this context, we studied samples from post-mortem cases with repetitive brain hypoxic episodes in the past history. We investigated, by immunohistochemistry, the presence of Bcl-2, c-jun and bax in CAm. CAm showed immunoreactivity for the mitochondrial membrane associated protein Bcl-2, and for the major component of activator protein 1 transcriptional factor c-Jun. We found higher numbers of CAm in the hippocampus and the dentate gyrus in cases with repetitive cerebral hypoxia than in controls. We conclude that: (1) the presence of C-Jun and Bcl-2 within the glucose polymer mass of CAm may be related to mitochondrial damage and/or a transient overload of proteolytic systems during cellular injury; and (2) repetitive cellular stress during life may cause the age-related increase of CAm in elderly subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903930     DOI: 10.1046/j.1365-2990.2001.00362.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  11 in total

1.  Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.

Authors:  He Meng; Xiaojie Zhang; Mila Blaivas; Michael M Wang
Journal:  Neuropathology       Date:  2009-04-28       Impact factor: 1.906

Review 2.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

3.  Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia.

Authors:  Jackie G Lee; Sia Dahi; Rajeev Mahimkar; Nathaniel L Tulloch; Maria A Alfonso-Jaume; David H Lovett; Rajabrata Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

4.  Osteopontin mediates the formation of corpora amylacea-like structures from degenerating neurons in the CA1 region of the rat hippocampus after ischemia.

Authors:  Tae-Ryong Riew; Xuyan Jin; Ji-Won Hwang; Soojin Kim; Hong Lim Kim; Mun-Yong Lee
Journal:  Cell Tissue Res       Date:  2022-06-11       Impact factor: 4.051

5.  Nimodipine modulates Bcl-2 and Bax mRNA expression after cerebral ischemia.

Authors:  Changqin Liu; Ruixiang Zhou; Shenggang Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration.

Authors:  Catalina Amador-Ortiz; Zeshan Ahmed; Cynthia Zehr; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2006-12-30       Impact factor: 17.088

7.  Corpora Amylacea of Brain Tissue from Neurodegenerative Diseases Are Stained with Specific Antifungal Antibodies.

Authors:  Diana Pisa; Ruth Alonso; Alberto Rábano; Luis Carrasco
Journal:  Front Neurosci       Date:  2016-03-08       Impact factor: 4.677

8.  Human and Microbial Proteins From Corpora Amylacea of Alzheimer's Disease.

Authors:  Diana Pisa; Ruth Alonso; Ana Isabel Marina; Alberto Rábano; Luis Carrasco
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

9.  Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?

Authors:  Troy T Rohn
Journal:  Int J Neurol Neurother       Date:  2015-08-28

10.  Exploring the elusive composition of corpora amylacea of human brain.

Authors:  Elisabet Augé; Jordi Duran; Joan J Guinovart; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.